Avidity
Brendan Winslow is an experienced finance executive currently serving as SVP of Finance at Avidity Biosciences, Inc. since December 2024. Prior to this role, Brendan held multiple senior positions at Acadia Pharmaceuticals Inc. from June 2017 to December 2024, including Vice President of Strategic Finance and Senior Director of FP&A. Brendan's extensive background also includes Vice President of Client Finance at Synchrony and Finance Manager at PepsiCo. Earlier career experience includes roles as Senior Financial Analyst at Baxter International Inc. and participation in a Financial Development Program. Brendan earned an MBA from Northwestern University's Kellogg School of Management and a BS in Finance, Summa Cum Laude, from Miami University, along with additional education in programming and international studies.
This person is not in any teams
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.